Clinical Trials Directory

Trials / Unknown

UnknownNCT05810883

Prevalence of IR in Overweight and Obese Adolescents

Prevalence and Risk Factors of Insulin Resistance in Overweight and Obese Adolescents

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine the prevalence of Insulin Resistance (IR) among overweight and obese adolescents using HOMA-IR scores and identify lifestyle risk factors in the IR and Non-IR group.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood Tests; Serum Fasting Insulin and GlucoseLaboratory results of blood samples, for high-density lipoprotein (HDL), low-density protein (LDL), triglycerides, and total cholesterol (TC) will be evaluated for this study. Fasting Insulin and fasting glucose levels will be used to calculate IR. Insulin Resistance will be calculated using Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (FPG (mmol/L) × FPI (mU/L)/22.5) \[21\] and defined as HOMA-IR ≥ 3.4

Timeline

Start date
2023-05-11
Primary completion
2024-02-01
Completion
2025-08-30
First posted
2023-04-13
Last updated
2023-04-28

Source: ClinicalTrials.gov record NCT05810883. Inclusion in this directory is not an endorsement.